PROTEONOMIX, INC. Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2013-10: Study NCT01818284; Company role Collaborator; Phase Phase 2; Status Completed.
- 2012-10: Study NCT01711073; Company role Lead sponsor; Phase Phase 1; Status Unknown.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2013-10 | NCT01818284 Plerixafor for Stem Cell Mobilization in Normal Donors | Collaborator Lead: M.D. Anderson Cancer Center | Phase 2 | Completed Results posted | Blood And Marrow Transplantation | 22 | 2016-06 |
| 2012-10 | NCT01711073 Mobilization of Stem Cells With G-CSF and Mozobil in Patients With End Stage Liver Disease | Lead sponsor | Phase 1 | Unknown | End Stage Liver DIsease | 15 | 2013-09 |